Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
Saved in:
Main Authors: | Katherine Neubecker, Beverley Adams-Huet, Irfan M. Farukhi, Rosinda Castanon, Ugis Gruntmanis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.1155/2017/4982312 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
by: Kristene Myklak, et al.
Published: (2011-01-01) -
Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
by: Matthew E. Johnson, et al.
Published: (2012-01-01) -
Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation
by: Bradley A. Wall, et al.
Published: (2015-01-01) -
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
by: Lior Z. Braunstein, et al.
Published: (2014-01-01) -
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
by: Rahul Aggarwal, et al.
Published: (2022-01-01)